State Board of Administration of Florida Retirement System’s Cyclerion Therapeutics CYCN Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio CYCN Stock Details CYCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-503	Closed	-$28K	–	2394
2021 Q1	$28K	Hold	503	–	–	﹤0.01%	2365
2020 Q4	$31K	Hold	503	–	–	﹤0.01%	2346
2020 Q3	$61K	Hold	503	–	–	﹤0.01%	2269
2020 Q2	$60K	Buy	+503	New	+$42.1K	﹤0.01%	2275

Other funds holding CYCN

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Board of Administration of Florida Retirement System's CYCN Position: Q2 2021 in Review

State Board of Administration of Florida Retirement System sold out of Cyclerion Therapeutics (CYCN) in Q2 2021, closing a stake of 503 shares — an estimated $28K sold.

State Board of Administration of Florida Retirement System first reported a position in CYCN in Q2 2020 and held it in 4 quarters. The position peaked at $61K in Q3 2020. 67 funds tracked by Wall St. Rank hold CYCN as of Q2 2021.

State Board of Administration of Florida Retirement System reported no remaining Cyclerion Therapeutics position as of Q2 2021 after selling out during the quarter.
State Board of Administration of Florida Retirement System sold 503 Cyclerion Therapeutics shares in Q2 2021, an estimated $28K.
State Board of Administration of Florida Retirement System first reported a position in Cyclerion Therapeutics in Q2 2020 and held it in 4 quarters.
State Board of Administration of Florida Retirement System's Cyclerion Therapeutics position peaked at $61K in Q3 2020.
67 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2021.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2021, filed 10 Aug 2021.